Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cancers
|
September 25, 2020
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, et al.
Ebiomedicine
|
June 21, 2024
Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice
Loris Roncali, Séverine Marionneau-Lambot, Charlotte Roy, et al.
Frontiers in Oncology
|
March 3, 2020
SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human
Floriane Etienne, Maxime Berthaud, Frédérique Nguyen, et al.
Plos One
|
August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb
Vincent Boudousq, Laure Bobyk, Muriel Busson, et al.
International Journal of Molecular Sciences
|
February 14, 2015
Tumor immunotargeting using innovative radionuclides
Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Oncotarget
|
March 7, 2018
Comparison of Immuno-PET of CD138 and PET imaging with <sup>64</sup>CuCl<sub>2</sub> and <sup>18</sup>F-FDG in a preclinical syngeneic model of multiple myeloma
Clément Bailly, Sébastien Gouard, Marie Lacombe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 13, 2024
Survival impact of [<sup>225</sup>Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases
Alexandre Lugat, Nicolas Chouin, Florian Chocteau, et al.
International Journal of Molecular Sciences
|
May 30, 2019
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between <sup>89</sup>Zr- and <sup>64</sup>Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model
Clément Bailly, Sébastien Gouard, François Guérard, et al.
Pharmaceutics
|
July 29, 2023
Preclinical Evaluation of a <sup>64</sup>Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma
Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Emmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cancers
|
September 25, 2020
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, et al.
Ebiomedicine
|
June 21, 2024
Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice
Loris Roncali, Séverine Marionneau-Lambot, Charlotte Roy, et al.
Frontiers in Oncology
|
March 3, 2020
SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human
Floriane Etienne, Maxime Berthaud, Frédérique Nguyen, et al.
Plos One
|
August 8, 2013
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb
Vincent Boudousq, Laure Bobyk, Muriel Busson, et al.
International Journal of Molecular Sciences
|
February 14, 2015
Tumor immunotargeting using innovative radionuclides
Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Oncotarget
|
March 7, 2018
Comparison of Immuno-PET of CD138 and PET imaging with <sup>64</sup>CuCl<sub>2</sub> and <sup>18</sup>F-FDG in a preclinical syngeneic model of multiple myeloma
Clément Bailly, Sébastien Gouard, Marie Lacombe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 13, 2024
Survival impact of [<sup>225</sup>Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases
Alexandre Lugat, Nicolas Chouin, Florian Chocteau, et al.
International Journal of Molecular Sciences
|
May 30, 2019
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between <sup>89</sup>Zr- and <sup>64</sup>Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model
Clément Bailly, Sébastien Gouard, François Guérard, et al.
Pharmaceutics
|
July 29, 2023
Preclinical Evaluation of a <sup>64</sup>Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma
Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Emmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.
Page
of 4